Avenue Therapeutics, Inc. SEC filings ATXI
Avenue Therapeutics, Inc. has 423 filings in SEC EDGAR's recent list, going back to Dec 30, 2015. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Feb 23, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| POS AM | Filing | Dec 15, 2025 | — |
| S-3 | Shelf registration | Dec 4, 2024 | — |
| S-8 | Employee stock plan registration | Jul 12, 2024 | — |
| 424B3 | Prospectus | May 10, 2024 | — |
| 424B5 | Prospectus supplement | May 10, 2024 | — |
| S-3 | Shelf registration | May 6, 2024 | — |
| 424B3 | Prospectus | Feb 2, 2024 | — |
| S-3 | Shelf registration | Jan 24, 2024 | — |
| 424B4 | Prospectus | Nov 2, 2023 | — |
| S-1/A | Amended registration statement | Oct 24, 2023 | — |
| FWP | Free writing prospectus | Oct 5, 2023 | — |
| FWP | Free writing prospectus | Oct 4, 2023 | — |
| S-1/A | Amended registration statement | Sep 29, 2023 | — |
| S-1 | Registration statement | Sep 18, 2023 | — |
| 424B3 | Prospectus | Jun 28, 2023 | — |
| S-3 | Shelf registration | Jun 16, 2023 | — |
| 424B3 | Prospectus | May 4, 2023 | — |
| S-1 | Registration statement | Apr 11, 2023 | — |
| S-8 | Employee stock plan registration | Feb 10, 2023 | — |
| 424B5 | Prospectus supplement | Jan 31, 2023 | — |
| 424B4 | Prospectus | Oct 11, 2022 | — |
| FWP | Free writing prospectus | Oct 6, 2022 | — |
| S-1/A | Amended registration statement | Oct 6, 2022 | — |
| S-1/A | Amended registration statement | Oct 5, 2022 | — |
| S-1 | Registration statement | Aug 31, 2022 | — |
| S-8 | Employee stock plan registration | Dec 17, 2021 | — |
| 424B5 | Prospectus supplement | Dec 13, 2021 | — |
| 424B5 | Prospectus supplement | Dec 10, 2021 | — |
| S-3 | Shelf registration | Dec 7, 2021 | — |
| 424B5 | Prospectus supplement | Nov 10, 2021 | — |
| 424B5 | Prospectus supplement | Nov 9, 2021 | — |
| S-3 | Shelf registration | Sep 28, 2021 | — |
| S-3/A | Form s-3/a | May 2, 2018 | — |
| S-3 | Shelf registration | Apr 13, 2018 | — |
| S-8 | Employee stock plan registration | Aug 15, 2017 | — |
| 424B2 | Prospectus | Jun 28, 2017 | — |
| S-1MEF | Filing | Jun 26, 2017 | — |
| S-1/A | Amended registration statement | Jun 23, 2017 | — |
| S-1/A | Amended registration statement | Jun 23, 2017 | — |
| S-1/A | Amended registration statement | May 22, 2017 | — |
| S-1 | Registration statement | Apr 28, 2017 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ATXI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bay Harbor Islands, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1644963
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.